Showing 5371-5380 of 6036 results for "".
- Provider Initiative to Help Ease Financial and Administrative Stress During Coronavirus Pandemichttps://modernod.com/news/provider-initiative-to-help-ease-financial-and-administrative-stress-during-coronavirus-pandemic/2477522/Humana announced a series of actions designed to help provide financial and administrative relief for the health care provider community facing the COVID-19 pandemic. First, Humana is implementing simplified and expedited claims processing in order to get reimbursement payments to provider
- Retina Specialists in US Hot Zones Report on How Offices, ORs Have Changed During COVID-19 Spreadhttps://modernod.com/news/retina-specialists-in-us-hot-zones-report-on-how-offices-ors-have-changed-during-covid-19-spread/2477521/New Retina Radio, Retina Today’s podcast, featured a conversation with three doctors from hotspots in the United States. John W. Kitchens, MD, moderated a conversation with George Williams, MD, from the Oakland University School of Medicine, outside of Detroit; Gwen Cousins, MD, from Ret
- Experts Provide Advice on How to Handle Staff and Ensure Business Survival When the Practice Closeshttps://modernod.com/news/ootg-webcast-experts-provide-advice-on-how-to-handle-staff-and-ensure-business-survival-when-the-practice-closes/2477517/In the latest episode of Ophthalmology off the Grid, cohosts Gary Wörtz, MD, and Blake Williamson, MD, MPH, touched base with practice management experts Bruce Maller and Matt Jensen who shed light on key areas of concern for practice leaders. Mr. Maller and Mr. Jensen provide insight on a variet
- FDA Calls for Withdrawal of Ranitidine Products as Review Finds Contaminant Could Pose Riskhttps://modernod.com/news/fda-calls-for-withdrawal-of-ranitidine-products-as-review-finds-contaminant-could-pose-risk/2477519/The FDA requested that manufacturers immediately pull all prescription and over-the-counter (OTC) ranitidine drugs from the market, saying new evidence indicates users could be exposed to “unacceptable levels” of the probable carcinogen N-nitrosodimethylamine (NDMA) over time under ce
- Philadelphia Teen Fires Up His 3D Printers to Create Face Shields to Donate to Hospitalshttps://modernod.com/news/philadelphia-teen-fires-up-his-3d-printers-to-create-face-shields-to-donate-to-hospitals/2477516/Louie Beardell was feeling kind of bored, what with his school on spring break and no chance to get outside and play sports with his buddies. He decided to try to save the world. Or one per
- Retina Industry Giants Temporarily Extend Payment Termshttps://modernod.com/news/retina-industry-giants-temporarily-extend-payment-terms/2477512/Genentech, Regeneron, Allergan, and Novartis are extending payment terms in response to the COVID-19 crisis. George Williams, MD, discussed the terms of extended payment by Genentech and Regeneron on a recent episode of New Retina Radio, and the details were confirmed by statements from th
- Vision Expo Announces Virtual Connections Program to Launch in Mid-Aprilhttps://modernod.com/news/vision-expo-announces-virtual-connections-program-to-launch-in-mid-april/2477509/Vision Expo has announced it will launch Virtual Connections, a new program designed to encourage and facilitate conversations and virtual meetings for Vision Expo East 2020 exhibitors and attendees who had registered for the event that was postponed as a result of COVID-19, according to a Vision
- Tatsuya Kaihara Appointed CEO of Santen Inc. and Head of North America Business of Santen Pharmaceuticalhttps://modernod.com/news/tatsuya-kaihara-appointed-ceo-of-santen-inc-and-head-of-north-america-business-of-santen-pharmaceutical/2477510/Santen announced the appointment of Tatsuya Kaihara as Corporate Officer and Head of North America Business of Santen Pharmaceutical. As of April 1, he is also appointed as CEO of Santen Inc. and he will lead the company’s North America business and report to Shigeo Taniuchi, P
- Allergan COVID-19 Response: Program Enhancementshttps://modernod.com/news/allergan-covid-19-response-program-enhancements/2477507/Allergan has announced several program enhancements designed to assist eye care professionals and patients during the COVID-19 pandemic. These include: Lowering copay savings card offerings for Restas
- CAD4COVID: X-Ray Analysis for Quick Triage in Corona Crisishttps://modernod.com/news/cad4covid-x-ray-analysis-for-quick-triage-in-corona-crisis/2477508/Thirona and Delft Imaging launched CAD4COVID, a new artificial intelligence tool that analyzes X-ray images and is intended to support healthcare specialists manage COVID-19 cases. The companies